James Allison - Insperity Ex Operations
ASF Stock | EUR 78.50 1.50 1.95% |
Insider
James Allison is Ex Operations of Insperity
Age | 54 |
Phone | 281 358 8986 |
Web | https://www.insperity.com |
James Allison Latest Insider Activity
Tracking and analyzing the buying and selling activities of James Allison against Insperity stock is an integral part of due diligence when investing in Insperity. James Allison insider activity provides valuable insight into whether Insperity is net buyers or sellers over its current business cycle. Note, Insperity insiders must abide by specific rules, including filing SEC forms every time they buy or sell Insperity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
James Allison over six months ago Disposition of 1841 shares by James Allison of Insperity at 100.29 subject to Rule 16b-3 |
Insperity Management Efficiency
The company has return on total asset (ROA) of 0.0825 % which means that it generated a profit of $0.0825 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4512 %, meaning that it generated $0.4512 on every $100 dollars invested by stockholders. Insperity's management efficiency ratios could be used to measure how well Insperity manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Alistair Cox | Hays plc | 62 | |
Kaye Maguire | PageGroup plc | N/A | |
MaryTeresa OBE | Hays plc | 67 | |
Sandra Henke | Hays plc | N/A | |
Navnit Singh | Korn Ferry | ||
Keith Waddell | Robert Half International | 66 | |
Joshua Vogel | Cross Country Healthcare | N/A | |
Kelvin Stagg | PageGroup plc | N/A | |
Nick Cox | Hays plc | N/A | |
Colin MS | Cross Country Healthcare | 55 | |
James Hilton | Hays plc | 45 | |
Evelyn CraneOliver | Robert Half International | N/A | |
Karen VargaSinka | Cross Country Healthcare | N/A | |
Bryan Ackermann | Korn Ferry | N/A | |
Patrick Hollard | PageGroup plc | 55 | |
Steve Hallam | PageGroup plc | N/A | |
Kevin Clark | Cross Country Healthcare | 62 | |
Tina Ling | Hays plc | N/A | |
John Martins | Cross Country Healthcare | 55 | |
Phillip Noe | Cross Country Healthcare | 52 | |
Michael Buckley | Robert Half International | 57 |
Management Performance
Return On Equity | 0.45 | |||
Return On Asset | 0.0825 |
Insperity Leadership Team
Elected by the shareholders, the Insperity's board of directors comprises two types of representatives: Insperity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Insperity. The board's role is to monitor Insperity's management team and ensure that shareholders' interests are well served. Insperity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Insperity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Suzanne Haugen, PR Mang | ||
Ross Astramecki, VP Sales | ||
JaNette Connell, Sr HR | ||
Paul Sarvadi, Chairman of the Board, CEO | ||
Douglas CPA, CFO Fin | ||
Thomas Gearty, Sr Devel | ||
Daniel Herink, Senior Vice President - Legal, General Counsel, Secretary | ||
Arthur Arizpe, Pres COO | ||
James Allison, Ex Operations | ||
Larry Shaffer, Sr Devel |
Insperity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Insperity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.45 | |||
Return On Asset | 0.0825 | |||
Profit Margin | 0.03 % | |||
Operating Margin | 0.04 % | |||
Current Valuation | 4 B | |||
Shares Outstanding | 37.85 M | |||
Shares Owned By Insiders | 5.89 % | |||
Shares Owned By Institutions | 91.98 % | |||
Price To Earning | 24.34 X | |||
Price To Book | 72.15 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Insperity Stock
When determining whether Insperity is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Insperity Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Insperity Stock. Highlighted below are key reports to facilitate an investment decision about Insperity Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Insperity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Insperity Stock please use our How to Invest in Insperity guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.